QQQ   444.35 (-0.11%)
AAPL   171.29 (-1.17%)
MSFT   419.96 (-0.35%)
META   486.13 (-1.57%)
GOOGL   150.76 (-0.07%)
AMZN   180.25 (+0.23%)
TSLA   177.93 (-1.06%)
NVDA   907.75 (+0.58%)
NIO   4.61 (-1.28%)
AMD   182.08 (+1.39%)
BABA   72.48 (+1.24%)
T   17.62 (+0.40%)
F   13.22 (+1.23%)
MU   118.11 (-0.86%)
CGC   9.94 (+4.08%)
GE   175.56 (-2.53%)
DIS   122.62 (+1.36%)
AMC   3.69 (-14.98%)
PFE   27.96 (+0.65%)
PYPL   67.52 (+1.43%)
XOM   115.72 (+0.65%)
QQQ   444.35 (-0.11%)
AAPL   171.29 (-1.17%)
MSFT   419.96 (-0.35%)
META   486.13 (-1.57%)
GOOGL   150.76 (-0.07%)
AMZN   180.25 (+0.23%)
TSLA   177.93 (-1.06%)
NVDA   907.75 (+0.58%)
NIO   4.61 (-1.28%)
AMD   182.08 (+1.39%)
BABA   72.48 (+1.24%)
T   17.62 (+0.40%)
F   13.22 (+1.23%)
MU   118.11 (-0.86%)
CGC   9.94 (+4.08%)
GE   175.56 (-2.53%)
DIS   122.62 (+1.36%)
AMC   3.69 (-14.98%)
PFE   27.96 (+0.65%)
PYPL   67.52 (+1.43%)
XOM   115.72 (+0.65%)
QQQ   444.35 (-0.11%)
AAPL   171.29 (-1.17%)
MSFT   419.96 (-0.35%)
META   486.13 (-1.57%)
GOOGL   150.76 (-0.07%)
AMZN   180.25 (+0.23%)
TSLA   177.93 (-1.06%)
NVDA   907.75 (+0.58%)
NIO   4.61 (-1.28%)
AMD   182.08 (+1.39%)
BABA   72.48 (+1.24%)
T   17.62 (+0.40%)
F   13.22 (+1.23%)
MU   118.11 (-0.86%)
CGC   9.94 (+4.08%)
GE   175.56 (-2.53%)
DIS   122.62 (+1.36%)
AMC   3.69 (-14.98%)
PFE   27.96 (+0.65%)
PYPL   67.52 (+1.43%)
XOM   115.72 (+0.65%)
QQQ   444.35 (-0.11%)
AAPL   171.29 (-1.17%)
MSFT   419.96 (-0.35%)
META   486.13 (-1.57%)
GOOGL   150.76 (-0.07%)
AMZN   180.25 (+0.23%)
TSLA   177.93 (-1.06%)
NVDA   907.75 (+0.58%)
NIO   4.61 (-1.28%)
AMD   182.08 (+1.39%)
BABA   72.48 (+1.24%)
T   17.62 (+0.40%)
F   13.22 (+1.23%)
MU   118.11 (-0.86%)
CGC   9.94 (+4.08%)
GE   175.56 (-2.53%)
DIS   122.62 (+1.36%)
AMC   3.69 (-14.98%)
PFE   27.96 (+0.65%)
PYPL   67.52 (+1.43%)
XOM   115.72 (+0.65%)
OTCMKTS:RGRX

RegeneRx Biopharmaceuticals (RGRX) Stock Price, News & Analysis

$0.0012
0.00 (0.00%)
(As of 03/27/2024 ET)
Today's Range
$0.0012
$0.0012
50-Day Range
N/A
52-Week Range
$0.00
$13.70
Volume
N/A
Average Volume
608 shs
Market Capitalization
$1,812.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RGRX stock logo

About RegeneRx Biopharmaceuticals Stock (OTCMKTS:RGRX)

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for the treatment of dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and HLB Therapeutics. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland.

RGRX Stock Price History

RGRX Stock News Headlines

Regenerx Biopharmaceuticals Inc RGRXD
Regenerx Biopharm In (RGRXD)
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
RGRX RegeneRx Biopharmaceuticals, Inc.
RegeneRx To Extend Consent Solicitation Vote
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Bristol-Myers to Split Off Mead Johnson
Clover Biopharmaceuticals Ltd (2197)
See More Headlines
Receive RGRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RegeneRx Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:RGRX
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$80,000.00
Book Value
($2.40) per share

Miscellaneous

Free Float
1,319,000
Market Cap
$1,812.00
Optionable
Not Optionable
Beta
2.60
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Dr. Allan L. Goldstein Ph.D. (Age 86)
    Founder, Chairman, Chief Scientific Officer & Chairman of Scientific Advisor Board
    Comp: $86.54k
  • Mr. J. J. Finkelstein (Age 72)
    President, CEO & Director
    Comp: $75.26k

RGRX Stock Analysis - Frequently Asked Questions

How have RGRX shares performed in 2024?

RegeneRx Biopharmaceuticals' stock was trading at $0.0012 at the beginning of 2024. Since then, RGRX stock has increased by 0.0% and is now trading at $0.0012.
View the best growth stocks for 2024 here
.

When did RegeneRx Biopharmaceuticals' stock split?

RegeneRx Biopharmaceuticals shares reverse split on Monday, August 14th 2023. The 1-100 reverse split was announced on Monday, August 14th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What other stocks do shareholders of RegeneRx Biopharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RegeneRx Biopharmaceuticals investors own include Biocept (BIOC), Fulcrum Therapeutics (FULC), OPKO Health (OPK), VBI Vaccines (VBIV), Vaxart (VXRT), AVEO Pharmaceuticals (AVEO), Palatin Technologies (PTN), Sorrento Therapeutics (SRNE) and Sierra Oncology (SRRA).

How do I buy shares of RegeneRx Biopharmaceuticals?

Shares of RGRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RGRX) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners